Brind.

Heidi Overton's nomination and leadership of the FDA

Picking up: 2 developments in the last 24 hours, 4 in the last 7 days Updated 7 minutes ago

The latest in this situation

  1. Overton's FDA nomination was withdrawn, ending the expected nomination
  2. Overton nomination to lead FDA reported, with Brenner floated for FDA leadership
  3. Overton formally nominated to lead FDA
  4. Overton confirmed as FDA commissioner succeeding Makary; Hawley seeks accountability

How it started

Contenders for the FDA commissioner role are being discussed, noting the agency oversees products accounting for one-fifth of consumer spending.

18 reports, 6 independent, last reported Sep 24. The briefing below covers this first event.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 6 independent outlets

Contenders for the FDA commissioner role are being discussed, noting the agency oversees products accounting for one-fifth of consumer spending.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. FDA appoints Overton to lead the agency amid continued Trump influence.1 source
  2. Heidi Overton is named FDA commissioner and vows strict oversight and legal action against black market drug sellers.1 source
  3. Trump is expected to nominate Heidi Overton to lead the Food and Drug Administration.Sub-event
  4. Trump administration seeks new FDA commissioner; Overton expected nomination.1 source
  5. Trump appoints Overton to lead the FDA amid political pressure and Makary's resignation.1 source
  6. Discussion of candidates for the FDA commissioner role.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
12 more outlets ran the same wire story